17 April 2026
17 April 2026
The regulator requires Lilly to evaluate the “unexpected serious” risks associated with Foundayo.
Cochrane’s research looked at 17 clinical trials of anti-amyloid drugs in Alzheimer’s disease.
Interna’s MNM molecules will be integrated with targeting approaches for enhancing functional activity.
Aligos remains eligible for up to $420m in milestones and tiered, high single-digit royalties on Amoytop’s net sales.
Amazon has already collaborated with Memorial Sloan Kettering Cancer Center with its AI software.
This guidance emphasises the potential of NGS methods in mitigating safety risks associated with therapies incorporating genome editing.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
